Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells
Luca Tamò(University of Bern), Thomas Geiser(University of Bern)
American Journal of Physiology-Lung Cellular and Molecular Physiology
September 13, 2018
Cited by 53
Related Papers
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence
|New England Journal of Medicine|2023|128
The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
|Stem Cell Research & Therapy|2014|70
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial
|BMC Nephrology|2018|33
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones
|Clinical Journal of the American Society of Nephrology|2025|1